Natalizumab Biosimilar - Research Grade: Dylight®488

Natalizumab Biosimilar - Research Grade: Dylight®488, Host: CHO Cells, Human IgG4-Kappa

Target: CD49d.

Concentration: 0.2mg/ml.

Formulation: This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• SKU: ICH4037D488-100UG
• Manufacturer: Ichorbio
• Manufacturer SKU: ICH4037D488-100UG
• Package Unit: 100μg
• Quantity Unit: STK
• Reactivity: Human
• Application: Flow Cytometry, Immunohistochemistry
• Isotype: Human IgG4-Kappa
• Host: Cell Line